Commentary: On the incidence of histological prostate cancer and the probable diagnosis of cases with tumours too small to produce symptoms or to attract attention on physical examination - The findings of Dr Arnold Rice Rich

International Journal of Epidemiology

Volumn 36, Issue 2, 2007, Pages 285-287

  Adolfsson, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Histological rate; Insignificant cancer; Latent cancer; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADVANCED CANCER; AUTOPSY; BLADDER CARCINOMA; CANCER INCIDENCE; CANCER SURVIVAL; CYSTECTOMY; DIGITAL RECTAL EXAMINATION; HISTOPATHOLOGY; HUMAN; IMPOTENCE; MALE; NOTE; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; SYMPTOM; TREATMENT OUTCOME; URINE INCONTINENCE;

AUTOPSY; HISTOLOGICAL TECHNIQUES; HUMANS; INCIDENCE; MALE; PHYSICAL EXAMINATION; PROSTATIC NEOPLASMS;

EID: 34447330700     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dym053     Document Type: Note

References (20)

1. Rich AR. On the frequency of occurrence of occult carcinoma of the prostate. J Urol 1935;33:215-23. Reprinted in Int J Epidemiol.
2. Bumpus HC, Jr. Carcinoma of the prostate: A clinical study of 1000 cases. Surg Gynecol Obstet 1926;43:150-55.
3. Nesbit RM, Plumb RT. Prostatic carcinoma; a follow-up on 795 patients treated prior to the endocrine era and a comparison of survival rates between these and patients treated by endocrine therapy. Surgery 1946;20:263-72.
4. Franks LM. latent carcinoma of the prostate. J Pathol Bacteriol 1954;68:603-6.
5. Franks LM. Latency and progression in tumours: The natural history of prostatic cancer. Lancet 1956;2:1037-39.
6. Sakr WA, Haas GP, Cassin BF, Pontes JE, Crissman JD. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 1993;150:379-85.
7. Sanches-Chapado M, Olmedilla G, Cabeza M, Donat E, Ruiz A. Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: An autopsy study. Prostate 2003;54 238-47.
8. Stamatiou K, Alevizos A, Agapitos A, Sofras F. Incidence of impalpable carcinoma of the prostate and of non-malignant and precarcinomatous lesions in Greek male population: An autopsy study. Prostate 2006;66:1319-28.
9. Stamey TA, Freiha FS, McNeal JE, Redwine EA, Wittemore AS, Schmid H-P. Localized prostate cancer. Relationship of tumour volume to clinical significance of prostate cancer. Cancer 1993;71:933-38.
10. Abdelhady M, Abusamra A, Pautier SE, Chin JL, Izawa JI. Clinically significant prostate cancer found incidentally in radical cystoprostatectomy specimens. BJU Int 2006.
11. Moutzouris G, Barbatis C, Plasitiaris D et al. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell cancer of the bladder. Scand J Urol Nephrol 1999;33:27-30.
12. Thompson IM, Goodman PJ, Tangen CM et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349:215-24.
13. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
14. Quinn M, Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: International comparisons. BJU Int 2002;90:162-73.
15. Kahn MA, Partin AW. Expectant management: An option for localized prostate cancer. Prostate Cancer P D 2005;8:311-15.
16. Bostwick DG, Adolfsson J, Burke HB et al. Epidemiology and statistical methods in prediction of patient outcome. Scand J Urol Nephrol 2005;216(Suppl):94-110.
17. Epstein JL, Amin M, Boccon-Gibaud L et al. Prognostic factors and reporting of prostatic carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. Scand J Urol Nephrol 2005;216(Suppl 34-63.
18. Etzioni R, Penson DF, Legelr JM et al. Over diagnosis due to prostate-spPcific antigen screening: Lessons form US: prostate cancer incidence trends. J Natl Cancer Inst 2002;94:981-90.
19. Pashayan N, Powles J, Brown C, Duffy SW. Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia. Br J Cancer 2006;95:401-5.
20. Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumour extent of nonpalpable (Stage Tlc) prostate cancer. JAMA 1994;271:368-74.